Medicilon has good preclinical trials services in drug development. Medicilon offers GLP and Non-GLP preclinical testing for the pharmaceutical and medical-device industries. We’re tremendously proud of our environmentally controlled animal facilities, surgery suites and necropsy labs. However, we understand they’re only a starting point for your preclinical studies.
Quick start experiments and flexible experimental design help you to speed up your decisions and lower your research cost.
Drug Metabolism and Pharmacokinetics
Pharmacology Services (Animal Models)
Perfect and Complete Preclinical Research Laboratories
Medicilon owns 30,000 square meters of R & D laboratories and high-end equipment. Our labs are certified by Association for Assessment and Accreditation of Laboratory Animal Care (AAALAC) and meet the GLP standard of US FDA and CFDA. Our preclinical safety evaluations also meet the Organization for Economic Cooperation and Development in Europe (OECD) GLP requirements.
Medicilon is the first CRO to offer preclinical animal testing service for the global pharmaceutical companies in China. Some of the platform provided by Medicilon such as Drugs Safety Evaluation for Non-Human Primates Services Platform and Isotope Drug Metabolism Professional Services Platform is certified by Shanghai government. In addition, our platform is certified and identified as an important drug discovery platform by Shanghai government. We provide cost effective, quality preclinical CRO services.
Preclinical Trials and Clinical Trials are the processes by which scientists test drugs and devices to see if they are SAFE and EFFECTIVE.
Preclinical Trial – Preclinical Trial is a laboratory test of a new drug or a new medical device, usually done on animal subjects, to see if the hoped-for treatment really works and if it is safe to test on humans.
Steps to New Drug Discovery Preclinical Trials
Step One: Get an idea for a drug target.
Step Two: Develop a Bioassay. A Bioassay is a “live” system that can be used to measure drug effect.
Step Three: Screen the drug in the Bioassay.
Step Four: Establish what dosage amount of the drug is safe and what dosage amount of the drug is toxic.
Step Five: Application is made to the Food and Drug Administration (FDA) as an Investigational New Drug (IND).
Email: marketing@medicilon.com
Tel: +86 021 58591500
Tips : Above is part of Preclinical Trials, Preclinical Studies, Preclinical Reasearch and non clinic Testing. You can also CONTACT US with any question or enquiry you may have. We will be happy to discuss your needs in detail and design an appropriate plan of action.
Preclinical studies and clinical trials of drugs
Relevant
news
marketing@medicilon.com
